Absolute change in plasma ALP from Baseline to Week 12 12 weeks [clinicaltrials_resource:ef0e8cd31bea7c0f4383abda58fc4d4e]

Absolute change in plasma ALP from Baseline to Week 12 12 weeks [clinicaltrials_resource:ef0e8cd31bea7c0f4383abda58fc4d4e]

NGM282 Dose 1
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:ef0e8cd31bea7c0f4383abda58fc4d4e
Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis [clinicaltrials:NCT02135536]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Absolute change in plasma ALP from Baseline to Week 12 12 weeks [clinicaltrials_resource:ef0e8cd31bea7c0f4383abda58fc4d4e]

NGM282 Dose 1
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:ef0e8cd31bea7c0f4383abda58fc4d4e
Bio2RDF identifier
ef0e8cd31bea7c0f4383abda58fc4d4e
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ef0e8cd31bea7c0f4383abda58fc4d4e
measure [clinicaltrials_vocabulary:measure]
Absolute change in plasma ALP from Baseline to Week 12
time frame [clinicaltrials_vocabulary:time-frame]
description
identifier
clinicaltrials_resource:ef0e8cd31bea7c0f4383abda58fc4d4e
title
Absolute change in plasma ALP from Baseline to Week 12 12 weeks
@en
inDataset
type
label
Absolute change in plasma ALP ...... e8cd31bea7c0f4383abda58fc4d4e]
@en